Physician profile
Michael Dougherty
NPI 1659675999
$8,214.63
in general payments reported to CMS, 2019-2025
28 companies · $2,002 in 2025
The $2,002 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,185 · 2022: $1,050 · 2023: $1,802 · 2024: $2,176 · 2025: $2,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,979.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,979.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,628.01 | 2021-2025 | Perclot, Tisseel, Floseal |
| W. L. Gore & Associates, INC. | $1,292.65 | 2021-2025 | Gore Seamguard Bioabsorbable Staple Line Reinforce, Gore Bio-A Tissue Reinforcement |
| Novo Nordisk INC | $835.60 | 2024-2025 | Wegovy |
| Gilead Sciences, INC. | $437.77 | 2022-2025 | |
| Amgen INC. | $385.27 | 2021-2025 | |
| Ethicon US, LLC | $333.01 | 2021-2024 | Stratafix, Dermabond Prineo, Ethicon |
| Abbvie INC. | $322.19 | 2023-2025 | |
| Sanofi Pasteur INC. | $277.99 | 2023 | |
| Intuitive Surgical, INC. | $276.67 | 2021-2024 | Da Vinci Surgical System |
| E.R. Squibb & Sons, L.L.C. | $241.96 | 2021 | |
| Sumitomo Pharma America, INC. | $240.68 | 2023-2024 | Myfembree |
| Alexion Pharmaceuticals, INC. | $240.05 | 2023-2024 | Ultomiris |
| Inspire Medical Systems, INC. | $217.23 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.91 | 2025 | |
| Inari Medical, INC. | $159.56 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $150.00 | 2023 | Recell |
| Teva Pharmaceuticals USA, INC. | $131.58 | 2021 | |
| Axsome Therapeutics, INC. | $125.00 | 2024 | Sunosi |
| Otsuka America Pharmaceutical, INC. | $121.98 | 2024 | |
| Coloplast Corp | $113.83 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $86.19 | 2025 | Xifaxan |
| Sk Life Science, INC. | $85.30 | 2022 | |
| Teleflex LLC | $73.95 | 2023 | Titan Sgs Standard Gastric Stapler |
| Biohaven Pharmaceuticals, INC. | $53.42 | 2021 | |
| Intra-Sana Laboratories | $50.00 | 2023 | Reltone 200 Mg, Reltone 400 Mg |
| Medical Device Business Services, INC. | $48.46 | 2024 | Echelon Flex |
| Sientra, INC. | $48.16 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $28.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.